Yayın:
Gadolinium-based contrast agents: <i>in vitro</i> paraoxonase 1 inhibition, <i>in silico</i> studies

Sadeleştirilmiş öğe sayfası
dc.contributor.authorBEYDEMİR, ŞÜKRÜ
dc.contributor.authorCüneyt Türkeş
dc.contributor.authorAhmet Yalçın
dc.contributor.orcid0000-0003-3667-6902
dc.contributor.orcid0000-0002-2932-2789
dc.contributor.orcid0000-0002-9708-0988
dc.date.accessioned2025-11-13T09:09:38Z
dc.date.issued2019-06-09
dc.identifier.doihttps://doi.org/10.1080/01480545.2019.1620266
dc.identifier.endpage517
dc.identifier.issn0148-0545
dc.identifier.issue5
dc.identifier.openalexW2952108153
dc.identifier.startpage508
dc.identifier.urihttps://hdl.handle.net/11421/630
dc.identifier.urihttps://doi.org/10.1080/01480545.2019.1620266
dc.identifier.volume44
dc.language.isoen
dc.relation.ispartofDrug and Chemical Toxicology
dc.rightsrestrictedAccess
dc.subjectGadodiamide
dc.subjectGadolinium
dc.subjectParaoxonase
dc.subjectChemistry
dc.subjectEnzyme
dc.subjectPharmacology
dc.subjectIC50
dc.subjectMedicine
dc.subjectIn vitro
dc.subjectBiochemistry
dc.subject.sdg3
dc.titleGadolinium-based contrast agents: <i>in vitro</i> paraoxonase 1 inhibition, <i>in silico</i> studies
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5081967794

Dosyalar

Koleksiyonlar

Publications